Key Points
- Bisoprolol is a highly selective beta-blocker, one of the most widely prescribed heart medications in the world, that works by reducing the heart rate and lowering the workload on the heart.
- In Australia, bisoprolol is PBS-listed specifically for heart failure with reduced ejection fraction, where it has strong evidence for improving survival. Internationally it is also widely used for high blood pressure, angina, and rate control in atrial fibrillation.
- Its cardioselectivity, the fact that it primarily targets the heart rather than the lungs or blood vessels, makes it better tolerated than older beta-blockers, including in some people with mild asthma or chronic lung disease.
- Bisoprolol should never be stopped suddenly without medical advice. Abrupt discontinuation can cause a rapid rise in heart rate or blood pressure.
- Common side effects include fatigue, dizziness, and cold hands and feet, most are mild and often improve over time. Always discuss any concerns with your doctor or pharmacist.
Bisoprolol is one of the most commonly prescribed heart medications in the world, and for good reason. It is effective, well tolerated, and has decades of evidence behind it. For many patients with heart failure, it is a cornerstone of treatment that has been shown to improve survival.
Despite how commonly it is prescribed, many patients have questions about what it actually does, why their dose is what it is, and whether the side effects they are experiencing are expected. This article aims to answer those questions clearly.
How Does Bisoprolol Work?
Bisoprolol belongs to a class of medications called beta-blockers. These work by blocking beta receptors, the sites in the body that respond to stress hormones like adrenaline. When adrenaline is blocked, the heart beats more slowly and with less force, reducing the workload it has to carry.
What makes bisoprolol distinctive is its selectivity. It is a beta-1 selective blocker, meaning it primarily targets the receptors in the heart rather than the beta-2 receptors found in the lungs and blood vessels. This matters clinically, non-selective beta-blockers can cause airways to narrow, which is a significant concern in people with asthma or chronic lung disease. Bisoprolol’s selectivity gives it a better safety profile in these patients, though it still requires careful discussion with the prescribing team.
The overall effect is a heart that beats more slowly, pumps with less strain, and, over time, remodels and functions more efficiently. In heart failure, this improvement in cardiac efficiency is one of the reasons bisoprolol has been shown to reduce hospitalisation and extend life.
Beta-blockers can seem counterintuitive in heart failure, patients sometimes ask how slowing the heart down can help a heart that’s already struggling. The answer is that in heart failure, the heart is often racing to compensate for its reduced pumping ability. Bisoprolol interrupts that cycle, giving the heart a chance to recover and work more efficiently over time.
— Prof. Peter Barlis, Interventional Cardiologist
Brand Names
Bisoprolol is available under several brand names depending on where in the world you are being treated. The medication is identical regardless of the name on the packet.
| Brand Name | Region |
|---|---|
| Bicor | Australia |
| Concor | Europe, Middle East, Asia |
| Zebeta | United States |
| Emcor / Cardicor | United Kingdom |
| Monocor | Canada, some European countries |
| Corbis | India and parts of Asia |
| Bisotab | Various countries |
When Is Bisoprolol Prescribed?
The answer to this question depends partly on where in the world you are being treated, and this is worth understanding clearly.
In Australia
In Australia, bisoprolol is listed on the Pharmaceutical Benefits Scheme (PBS) specifically for heart failure with reduced ejection fraction, a form of heart failure where the heart’s pumping function is measurably reduced. This is the condition for which bisoprolol has the strongest and most robust evidence, including large randomised trials showing significant improvements in outcomes and reductions in hospitalisation.
This PBS restriction means that Australian patients prescribed bisoprolol are most commonly heart failure patients. It does not mean bisoprolol cannot be used for other conditions, but those prescriptions would be outside the subsidised indication.
Internationally
In many other countries, bisoprolol is routinely prescribed across a broader range of cardiovascular conditions, including:
- High blood pressure (hypertension) bisoprolol reduces blood pressure by lowering heart rate and cardiac output
- Stable angina by reducing the heart’s oxygen demand, bisoprolol reduces the frequency and severity of angina episodes
- Atrial fibrillation bisoprolol is widely used internationally for rate control in AF, slowing a rapid irregular heart rate to a more comfortable and safer level
- After a heart attack beta-blockers have a well-established role in reducing the risk of further cardiac events after a myocardial infarction
reduction in adverse outcomes demonstrated with bisoprolol in the landmark CIBIS-II trial, one of the strongest evidence bases for any heart failure medication, and the reason it is now a cornerstone of treatment
CIBIS-II Investigators, The Lancet, 1999
Bisoprolol in Asthma and Lung Disease
One of the most common questions patients ask, and one of the most important, is whether bisoprolol is safe if they have breathing problems or lung disease.
Older, non-selective beta-blockers can constrict the airways and worsen asthma or chronic obstructive pulmonary disease (COPD). Bisoprolol’s cardioselectivity, its preference for heart receptors over lung receptors, gives it a significantly better profile in these patients. At the doses typically used in clinical practice, bisoprolol is generally well tolerated in people with mild-to-moderate asthma or COPD.
That said, cardioselectivity is not absolute, at higher doses, some airway effects can still occur. Anyone with significant lung disease should have a careful discussion with their cardiologist and respiratory team before starting bisoprolol, and should report any new or worsening breathlessness promptly.
How Is It Taken?
Bisoprolol is taken once daily, usually at the same time each morning. It is available in several strengths, most commonly 1.25 mg, 2.5 mg, 5 mg, and 10 mg tablets. In heart failure, the standard approach is to start at a low dose and increase slowly over weeks to months, a process called titration, allowing the heart to adjust gradually.
If you miss a dose, take it as soon as you remember, unless it is close to the time for your next dose, in which case simply skip the missed dose and continue as normal. Never take two doses at once.
Most importantly: do not stop taking bisoprolol suddenly without speaking to your doctor first. Abrupt discontinuation can cause the heart rate and blood pressure to rise sharply, a rebound effect that can be uncomfortable and potentially harmful. If you need to stop for any reason, your doctor will guide you through a gradual reduction.
Possible Side Effects
Most people take bisoprolol without significant problems. Side effects, when they do occur, are often mild and tend to improve as the body adjusts over the first few weeks.
|
Very Common Fatigue and low energy Feeling more tired than usual is the most commonly reported side effect, particularly in the first few weeks. For most people it settles over time as the body adjusts. If it persists or significantly affects daily life, mention it at your next appointment. |
Common Dizziness or lightheadedness Most noticeable when standing up quickly. This is due to a slight drop in blood pressure and usually improves over time. Rising slowly from sitting or lying positions can help. Let your doctor know if it is frequent or causes you to feel unsteady. |
|
Common Bisoprolol reduces blood flow to the extremities, which can make hands and feet feel noticeably colder. Keeping warm helps. If you already have Raynaud’s phenomenon, let your prescribing team know as bisoprolol can make this worse. |
Common Slow heart rate Bisoprolol is designed to slow the heart rate, so a lower than usual pulse is expected. Your doctor will monitor this. If your pulse feels very slow, or you feel faint or unusually unwell, contact your doctor promptly. |
|
Less Common Vivid dreams or sleep disturbance Some people notice more vivid dreams or lighter sleep. Taking bisoprolol in the morning rather than at night can sometimes help, discuss this with your doctor before making any changes. |
Discuss With Your Doctor Breathlessness Although bisoprolol is more selective for the heart than older beta-blockers, new or worsening breathlessness should always be reported to your doctor, particularly if you have asthma or lung disease. Do not stop the medication without speaking to your team first. |
If side effects feel significant or are affecting your quality of life, speak to your doctor or pharmacist before making any changes to your dose.
Questions Worth Asking at Your Next Appointment
- What specific condition is bisoprolol being prescribed for, and what is the target dose we are working toward?
- How quickly will my dose be increased, and what symptoms should I watch for during titration?
- I have asthma, is bisoprolol still appropriate for me, and what should I watch for?
- My hands and feet have become much colder since starting bisoprolol, is this expected, and is there anything that can be done?
- I feel more tired than before, is this likely to improve, and how long should I give it?
- What should I do if I accidentally miss a dose or need to stop the medication?
Heart Matters Resource
When in Doubt, Get Checked Out
If you experience new or worsening breathlessness, an unusually slow pulse, significant dizziness, or any other symptom that concerns you while taking bisoprolol, contact your doctor before making any changes to your medication.
Conclusion
Bisoprolol is one of the most important and well-evidenced medications in cardiovascular medicine, particularly for heart failure, where decades of trial evidence demonstrate its ability to improve survival and reduce hospitalisation. Its cardioselectivity makes it generally better tolerated than older beta-blockers, including in many patients with lung disease.
Understanding why it has been prescribed, what the target dose is, and what to expect along the way makes a real difference to how confidently patients can stay on treatment. If you have questions about bisoprolol and your specific situation, your cardiologist, GP, or cardiac nurse are the right people to ask.
Sources and Further Reading
CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). The Lancet, 1999. · McDonagh TA et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 2021. · Australian Pharmaceutical Benefits Scheme, bisoprolol fumarate listing. PBS Online, current edition.
